The relationship between response to phenelzine and acetylator status in depressed patients.
作者信息
Johnstone E C, Marsh W
出版信息
Proc R Soc Med. 1973 Sep;66(9):947-9. doi: 10.1177/003591577306600959.
Abstract
摘要
相似文献
1
The relationship between response to phenelzine and acetylator status in depressed patients.抑郁症患者对苯乙肼的反应与乙酰化状态之间的关系。
Proc R Soc Med. 1973 Sep;66(9):947-9. doi: 10.1177/003591577306600959.
2
Acetylator status and response to phenelzine in depressed patients.抑郁症患者的乙酰化状态及对苯乙肼的反应。
Lancet. 1973 Mar 17;1(7803):567-70. doi: 10.1016/s0140-6736(73)90715-0.
3
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.接受苯乙肼治疗的抑郁症患者中乙酰化状态与单胺氧化酶抑制、游离药物排泄及抗抑郁反应之间的关系。
Psychopharmacologia. 1976 Apr 15;46(3):289-94. doi: 10.1007/BF00421116.
4
Relationship between acetylator status and response to phenelzine.乙酰化状态与苯乙肼反应之间的关系。
Mod Probl Pharmacopsychiatry. 1975;10:30-7. doi: 10.1159/000397917.
5
Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Am J Psychiatry. 1978 Apr;135(4):467-9. doi: 10.1176/ajp.135.4.467.
6
Acetylator status and response to phenelzine.乙酰化状态与对苯乙肼的反应。
Lancet. 1978 Nov 25;2(8100):1151-2. doi: 10.1016/s0140-6736(78)92307-3.
7
Letter: Phenelzine and acetylator status.信件：苯乙肼与乙酰化状态。
Lancet. 1974 Aug 17;2(7877):412. doi: 10.1016/s0140-6736(74)91798-x.
8
The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.在一项临床试验中，乙酰化代谢表型对苯乙肼治疗结果的影响。
Br J Clin Pharmacol. 1978 Sep;6(3):247-54. doi: 10.1111/j.1365-2125.1978.tb04593.x.
9
Phenelzine: acetylator status and clinical response.苯乙肼：乙酰化状态与临床反应。
Br J Clin Pharmacol. 1979 May;7(5):451-2. doi: 10.1111/j.1365-2125.1979.tb00985.x.
10
Influence of acetylator phenotype on antidepressant effects of phenelzine.乙酰化代谢表型对苯乙肼抗抑郁作用的影响。
Br J Psychiatry. 1982 Sep;141:243-8. doi: 10.1192/bjp.141.3.243.
引用本文的文献
1
Variability in response to drugs.药物反应的变异性。
Br Med J. 1974 Oct 12;4(5936):91-4. doi: 10.1136/bmj.4.5936.91.
2
Genetically determined variability in acetylation and oxidation. Therapeutic implications.乙酰化和氧化的基因决定变异性。治疗意义。
Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003.
本文引用的文献
1
THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.抑郁综合征的诊断及电休克治疗反应的预测
Br J Psychiatry. 1965 Aug;111:659-74. doi: 10.1192/bjp.111.477.659.
2
THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.乙酰化酶表型对苯乙肼治疗抑郁症效果的影响。
Clin Pharmacol Ther. 1965 Jul-Aug;6:430-5. doi: 10.1002/cpt196564430.
3
HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性
J Lab Clin Med. 1964 Mar;63:394-403.
4
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
5
A standardized psychiatric interview for use in community surveys.用于社区调查的标准化精神病学访谈。
Br J Prev Soc Med. 1970 Feb;24(1):18-23. doi: 10.1136/jech.24.1.18.
6
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
7
Acetylator status and response to phenelzine in depressed patients.抑郁症患者的乙酰化状态及对苯乙肼的反应。
Lancet. 1973 Mar 17;1(7803):567-70. doi: 10.1016/s0140-6736(73)90715-0.
Zotero 插件